Rapid disease progression after the administration of bicalutamide in patients with metastatic prostate cancer

By Laufer M.   Sinibaldi V.J.   Carducci M.A.   Eisenberger M.A.  

Urology, Vol. 54, Iss. 4, 1999-10 ,pp. : 745-745

Elsevier

Access to resources Recommend Favorite

Cancer of the prostate: a nutritional disease?

By Fair W.R.   Fleshner N.E.   Heston W.  

Urology, Vol. 50, Iss. 6, 1997-12 ,pp. : 840-848

Elsevier

Access to resources Recommend Favorite

Androgen independent progression in prostate cancer: Risk factors

By Auzanneau C.   Irani J.   Dahmani L.   Ouaki F.   Pires C.   Dore B.  

European Urology Supplements, Vol. 2, Iss. 1, 2003-02 ,pp. : 26-26

Elsevier

Access to resources Recommend Favorite

Serum prostate-specific antigen and the biologic progression of prostate cancer

By Kabalin J.N.   McNeal J.E.   Johnstone I.M.   Stamey T.A.  

Urology, Vol. 46, Iss. 1, 1995-07 ,pp. : 65-70

Elsevier

Access to resources Recommend Favorite

Nadir prostate-specific antigen as a predictor of progression to androgen-independent prostate cancer

By Benaim E.A.   Pace C.M.   Lam P.M.   Roehrborn C.G.  

Urology, Vol. 59, Iss. 1, 2002-01 ,pp. : 73-78

Elsevier

Access to resources Recommend Favorite